Geo Group Approved for REIT Status and 4 Stocks Hitting 52-Week Highs

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Biomarin Pharmaceuticals (NASDAQ:BMRN): Closing price $54.08

BioMarin’s Achondroplasia treatment wins FDA Orphan Drug designation. Shares closed up 0.97 percent on the day at$54.08, and have traded in a 52-week range of $31.91 to $53.84.

bio

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business